XTX Topco’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

XTX Topco’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-181,068	Closed	-$2.9K	–	2318
2023 Q3	$2.9K	Buy	+181,068	New	+$24K	﹤0.01%	1485
2022 Q2	–	Sell	-38,519	Closed	-$44K	–	1169
2022 Q1	$44K	Sell	38,519 -131	-0.3%	-$157	0.02%	602
2021 Q4	$87K	Buy	38,650 +20,419	+112%	+$51.3K	0.05%	488
2021 Q3	$62K	Buy	+18,231	New	+$56.2K	0.02%	594

Other funds holding INFI

HCM

Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return

AWM

Able Wealth Management Toms River, New Jersey $455M AUM 13.63% 1-Year Est. Return

LFA

Livelsberger Financial Advisory Ashland, Ohio $2.68M AUM 23.21% 1-Year Est. Return

XTX Topco's INFI Position: Q4 2023 in Review

XTX Topco sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2023, closing a stake of 181,068 shares — an estimated $2.9K sold.

XTX Topco first reported a position in INFI in Q3 2021 and held it in 4 quarters. The position peaked at $87K in Q4 2021. 3 funds tracked by Wall St. Rank hold INFI as of Q4 2023.

XTX Topco reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
XTX Topco sold 181,068 Infinity Pharmaceuticals, Inc. shares in Q4 2023, an estimated $2.9K.
XTX Topco first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2021 and held it in 4 quarters.
XTX Topco's Infinity Pharmaceuticals, Inc. position peaked at $87K in Q4 2021.
3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2023.

Based on XTX Topco's 13F filing for Q4 2023, filed 13 Feb 2024.